Impact of COVID-19 Pandemic on Initiation of Immunosuppressive Treatment in Immune-Mediated Inflammatory Diseases in Austria: A Nationwide Retrospective Study.

Maximilian KutscheraValentin Ritschl Berthold Reichardt Tanja Alexandra StammHans KienerHarald MaierWalter ReinischBernhard BenkaGottfried Novacek

Published in: Journal of clinical medicine (2022)

In IMID patients, the COVID-19 pandemic led to a significant decrease of newly started conventional immunosuppressive and advanced targeted therapies only during the first lockdown in Austria.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
oxidative stress
combination therapy